Xpert® Xpress CoV-2/Flu/RSV plus by Cepheid

Manufacturer Cepheid  |   Model: XP3COV2/FLU/RSV-10
4.7
/
5.0
  |  1 reviews
Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses
The supplier does not provide quotations for this product through SelectScience. Browse these related products instead


Xpert® Xpress CoV-2/Flu/RSV plus by Cepheid product image
Xpert® Xpress CoV-2/Flu/RSV plus

Cepheid

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.




Average Rating: 4.7
1 Scientist has reviewed this product

5 out of 5
Ease of use
4 out of 5
After sales service
5 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2023

  • Organization: Mercy Hospital Lincoln



  • Ease of use
    5 out of 5
    After sales service
    4 out of 5
    Value for money
    5 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
LOVE this machine. Wouldn't want to run this lab without it!
Rating: 4.7

  • Application Area: Run samples in a hospital laboratory setting

"This machine has been a saving grace for our hospital. We were using one Liat and our testing was getting so backed up, causing delays in patient care (we could only run 1 at a time and it took 20 minutes. This ahs increased our TAT and patient throughput."

Review date: 15 Dec 2023 | Xpert® Xpress CoV-2/Flu/RSV plus

The Need
Rapidly detect SARS-CoV-2, including emerging variants, to provide timely and effective results
Accurately detect respiratory tract infections to ensure appropriate patient treatment
Differentiate Flu A, Flu B, RSV, and CoV-2 along with potential co-infections during the respiratory season
Full test runtime is 36 minutes. SARS-CoV-2 positive results available in as soon as 25 minutes with early assay termination.

The Solution
Actionable detection of SARS-CoV-2 in as little as 25 minutes, with results for all four pathogens in just 36 minutes
Robust design with multiple gene targets offers broader coverage to mutations
Rapid sample to answer provides actionable results from a single sample with less than one minute of hands-on time
Standardization of results by running the same assay in the central lab and decentralized testing sites

The Impact
Ensures that patients receive appropriate treatment in a timely manner
Supports clinicians with broader coverage for CoV-2 variants and Flu mutations
Single cartridge with an easy-to-use workflow, enabling hospitals to effectively manage limited resources

Product Overview

Xpert® Xpress CoV-2/Flu/RSV plus by Cepheid product image

Xpert® Xpress CoV-2/Flu/RSV plus

Manufacturer Cepheid

4.7 / 5.0 | 1 reviews